DR IRA A Horowitz MD

Ioannis Konstantinidis, M.D. in El Paso, TX, specializes in the treatment of cancer and blood disorders, offering a comprehensive range of services including chemotherapy, immunotherapy, and surgical oncology. The clinic is dedicated to providing personalized patient care through advanced treatment options and support services tailored to individual needs. In addition to standard cancer treatments, the facility also focuses on innovative therapies such as precision medicine and proton therapy, alongside patient support resources like nutritional counseling and genetic risk evaluation. With a commitment to advancing oncology care, the team at Texas Oncology strives to enhance the patient experience and improve outcomes for those facing cancer. Generated from the website

Ragene R Rivera, MD, is part of Texas Oncology PA in El Paso, TX, specializing in the treatment of cancer and blood disorders. The facility offers a comprehensive range of services including chemotherapy, immunotherapy, and surgery, alongside innovative treatments like precision medicine and proton therapy. In addition to direct medical care, Texas Oncology PA emphasizes patient support through educational services, financial counseling, and genetic risk evaluation. Their commitment to advancing oncology care is evident in their involvement in clinical trials and research initiatives aimed at improving treatment outcomes for patients. Generated from the website

Arsenio G Lopez, MD - Texas Oncology PA, located in El Paso, TX, is part of The US Oncology Network, which provides over 25 years of oncology practice management expertise. The organization is dedicated to delivering innovative, patient-centric cancer care through cutting-edge clinical trials and the support of a robust network of affiliated providers. With a commitment to maintaining the independence of local practices, Texas Oncology leverages the resources and experience of McKesson to enhance practice growth, operational efficiency, and physician satisfaction. They prioritize collaboration and advocacy within the oncology community to shape the future of cancer treatment. Generated from the website